Asia-Pacific Region to Grow at the Highest CAGR During the Forecast Period for the Single Cell Sequencing Market

According to the new market intelligence report by BIS Research titled “Global Single Cell Sequencing Market- Analysis and Forecast, 2018-2029”, the global single cell sequencing market was valued at $1.23 billion in 2018 and is anticipated to grow over $5.98 billion by 2029. The global single cell sequencing market is expected to grow at a double-digit CAGR of 15.24% during the forecast period from 2018 to 2029. The market growth is driven by factors such as advancements in single cell sequencing techniques and the increasing need for non-invasive diagnosis.

View BIS Research Report: https://bisresearch.com/industry-report/single-cell-sequencing-market.html

The global single cell sequencing market is undergoing a significant flux with advancements that have already taken place, and those currently invading the market space. Additionally, with the advancements in healthcare applications such as companion diagnostics, biomarkers, and next-generation sequencing, the demand for precise drugs and tests has increased considerably.

Advancements that have led to the recent success of diagnostic tests are non-invasive pre-natal testing (NIPT) and liquid biopsy. These have propelled the growth of the biomarker discovery field and initiated considerable research studies. Single cell sequencing technology enables the comprehensive profiling of a single cell by overcoming the challenges of heterogeneity associated with bulk cell populations. With the introduction of imaging solutions and single cell automated systems on a full scale, a paradigm shift in the dynamics of the market is expected to be witnessed by 2029.

The global single cell sequencing market is divided into two main categories, instruments and consumables. The kits and consumables are expected to witness impressive growth. This reflects the dependency of the single cell sequencing market on consumables, which is expected to continue to grow in the future.

The single cell sequencing technology has found its application in the diagnosis of various types of cancers, neurodegenerative diseases, non-invasive pre-natal diagnosis, genetic evaluation for in-vitro fertilization, and stem cell biology, among others. Analysis of circulating tumor cells (CTCs) at a single cell resolution has revealed their phenotypic diversity and progression of the disease, leading to widespread adoption of single cell analysis.

According to Nitish Kumar Singh, Lead Analyst at BIS Research, “North America is the leading contributor to the global single cell sequencing market and contributed approximately 45.8% to the global market value in 2019. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period from 2018-2029. The Europe region further contributed a significant share of 26.6% to the global market and is projected to grow at an impressive CAGR of 14.70% during the forecast period from 2018-2029.”

Request for a Sample: https://bisresearch.com/requestsample?id=816&type=download

This single cell sequencing market intelligence report is a comprehensive study that includes research on more than 50 players operating in the market ecosystem. The key players profiled in the report include 10x Genomics, Inc., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Celsee, Inc., BGI Genomics Co. Ltd. GE LifeSciences, Illumina, Inc., Takara Bio, Inc., Perkin Elmer, and Inc. QIAGEN N.V.

Key Questions Answered in the Report
 How much revenue was generated by the global single cell sequencing market in 2018, and how much revenue is expected to be generated by the market by 2029?
 What are the major market drivers, challenges, and opportunities in the global single cell sequencing market?
 How is each segment of the global single cell sequencing market expected to grow during the forecast period?
 Following are the segments:
o workflow, including single cell isolation, single cell amplification, single cell sequencing, and affiliated technological advancement
o product, including instruments and consumables
o applications, including oncology, immunology, neurology, microbiology, pre-natal diagnosis (NIPT), and others
o end user, including end-user type (research and academic laboratories, biopharmaceutical and biotech companies, and others)
o region, including North America, Europe, Asia-Pacific, Latin America, Rest-of-the-World
 What are the key development strategies implemented by the major players in order to sustain in the competitive market?
 What are the key regulatory implications in developed and developing regions for single cell sequencing technology?
 Who are the leading players with significant offerings to the global single cell sequencing market? What is the current market dominance for each of these leading players?

Contact:
Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch

About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.
Our in-depth market intelligence reports focus on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.

This release was published on openPR.